Drugs / intravenous immunoglobulin G
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00177970 Comparator | Oct 2003 → Apr 2008 | Clostridium difficile colitis | University of Pittsburgh | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intravenous immunoglobulin G | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00177970 ↗ |
| Known as | IVIG | “intravenous immunoglobulin G (IVIG)” NCT00177970 ↗ |
| Route | Intravenous | “IVIG to be given IV to patients with C-Diff .” NCT00177970 ↗ |